Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Skin Toxicity × Tablets × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Polycystic Ovary Syndrome 7 Neoplasms 3 Endometrial Neoplasms 3 Prostatic Neoplasms 2 Obesity 2 Multiple Myeloma 2 Melanoma 2 Leukemia, Myeloid, Acute 2 Leiomyoma 2 Insulin Resistance 2 Inflammation 2 Infertility, Female 2 Glioblastoma 2 Colorectal Neoplasms 2 Cardiotoxicity 2 Weight Gain 1 Vomiting 1 Venous Thromboembolism 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Thrombocythemia, Essential 1 Stem Cell Transplant Complications 1 Smoking 1 Skin Toxicity 1 Sarcoma 1 Resectable Pancreatic Ductal Adenocarcinoma 1 Recurrence 1

Interventions

Tablets 1 Doxycycline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03448731 2020-04-08

DERMIA

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 2 Completed

Skin Toxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡